Navigation Links
Autonomy(TM) Lapro-Angle(TM) Articulating Laparoscopic Instruments Granted CE Mark

Leader In Single Port Access Surgery Achieves Another Milestone

FRAMINGHAM, Mass., Aug. 4 /PRNewswire/ -- Cambridge Endo, a pioneer in the rapidly emerging Single Port Access (SPA) surgery market, is pleased to announce that it has been granted a CE Mark for its innovative Autonomy(TM) Lapro-Angle(TM) Articulating Laparoscopic Instruments.

In traditional laparoscopic surgery, the surgeon makes four to six "keyhole" incisions, inserts instrumentation into each "keyhole" and performs the surgery. This represented a major advance over the pain, scarring and long recovery times associated with open surgery. Nevertheless, the patient is left with the cosmetic, pain and recovery time issues associated with four to six incisions.

According to Woojin Lee, president and founder, "Single Port Access surgery has been called 'scarless surgery.' In single port surgery, only one incision is made through the umbilicus (belly button) instead of four to six incisions. All of the instruments go through this single 'keyhole.' To maneuver effectively in such a restricted space, the surgeon must have highly maneuverable instrumentation. Traditional straight laparoscopic instruments are inadequate." Continued Lee, "With the ability to articulate, rotate and lock, our Autonomy(TM) Lapro-Angle(TM) instruments vastly improve the surgeon's dexterity in tight spaces. We believe that our Autonomy(TM) Lapro-Angle(TM) instruments will be the enabling technology that drives the rapid uptake of this major advance in surgery.

Recently, the 11th donor kidney was removed through a Single Port Access procedure at the Cleveland Clinic. According to the clinic, the return to work time for single port surgery donors is about 17 days vs. 51 for traditional multi-incision laparoscopic procedures. Lee commented, "This shows that even complicated, delicate procedures can be performed utilizing the single port approach. We believe that a large proportion of the 2.5 million laparoscopic procedures currently performed in the U.S. will convert to the single port access technique due to the compelling patient benefits that it offers. With the CE Mark in place, surgeons in Europe will now be able to offer this exciting technique to their patients."

About Cambridge Endo

Cambridge Endo is a privately held medical device company that designs, develops and manufactures innovative articulating laparoscopic instruments. The Autonomy(TM) Lapro-Angle(TM) product line is an enabling technology for Single Port Access surgery. Autonomy articulating instruments are also used in many traditional laparoscopic procedures by general surgeons, bariatric surgeons, urologic surgeons, gynecologic surgeons and other surgical specialties.

Cambridge Endo is headquartered in Framingham, MA. For more information about Cambridge, please visit


Woojin Lee, Ph.D.


SOURCE Cambridge Endo
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Novare Announces First Ever Single Port Laparoscopic Kidney Removal (Nephrectomy) Using RealHand(TM) HD Instruments
2. Young Physicians Demanding Advanced Laparoscopic Energy Instruments
3. Encision Launches Next Generation of EnTouch(R) Handles for Advanced Laparoscopic Procedures
4. Society of Laproendoscopic Surgeons Names Starion Instruments 2007 Innovator of the Year
5. Advanced Instruments Introduces Worlds Fastest High Throughput Freezing Point Osmometer
6. Nikon Instruments Launches New Eclipse Ti-E Fully-Integrated, Motorized Inverted Microscope
7. Advanced Instruments Acquires Mart Microbiology B.V.
8. Nikon Instruments Introduces NIS-Elements Software for Eclipse Ti-E Live-Cell Applications
9. Neogen Acquires Assets of Rivard Instruments
10. Nikon Instruments Partners With Koshland Science Museum to Create the Museums First-Ever Microbe Lab
11. Nikon Instruments Launches Fully-Automated A1 Confocal Laser Microscope Series
Post Your Comments:
(Date:11/24/2015)... Nov. 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ... New York on Wednesday, December 2 at ... , president and CEO, will provide a corporate overview. ... at 1:00 p.m. ET/10:00 a.m. PT . ... will provide a corporate overview. --> th Annual ...
(Date:11/24/2015)... -- Clintrax Global, Inc., a worldwide provider of clinical research services headquartered ... the company has set a new quarterly earnings record in Q3 ... posted for Q3 of 2014 to Q3 of 2015.   ... , with the establishment of an Asia-Pacific ... United Kingdom and Mexico , with ...
(Date:11/24/2015)... , November 24, 2015 ... market research report released by Transparency Market Research, the ... at a CAGR of 17.5% during the period between ... Market - Global Industry Analysis, Size, Volume, Share, Growth, ... non-invasive prenatal testing market to reach a valuation of ...
(Date:11/24/2015)... ... ... InSphero AG, the leading supplier of easy-to-use solutions for production, culture, and ... as Chief Operating Officer. , Having joined InSphero in November 2013 as ... promoted to Head of InSphero Diagnostics in 2014. There she has built up ...
Breaking Biology Technology:
(Date:10/29/2015)... 2015  Rubicon Genomics, Inc., today announced an ... its DNA library preparation products, including the ThruPLEX ... Plasma-seq kit. ThruPLEX Plasma-seq has been optimized for ... libraries for liquid biopsies--the analysis of cell-free circulating ... in cancer and other conditions. Eurofins Scientific is ...
(Date:10/29/2015)... Oct. 29, 2015 Today, LifeBEAM ... partnership with 2XU, a global leader in technical ... smart hat with advanced bio-sensing technology. The hat ... to monitor key biometrics to improve overall training ... the two companies will bring together the most advanced ...
(Date:10/27/2015)... 2015 Synaptics Inc. (NASDAQ: SYNA ), the ... has adopted the Synaptics ® ClearPad ® ... its newest flagship smartphones, the Nexus 5X by LG ... --> --> Synaptics works closely ... collaboration in the joint development of next generation technologies. ...
Breaking Biology News(10 mins):